Single-cell transcriptomic Atlas of aging macaque ocular outflow tissues

Abstract

The progressive degradation in the trabecular meshwork (TM) is related to age-related ocular diseases like primary open-angle glaucoma. However, the molecular basis and biological significance of the aging process in TM have not been fully elucidated. Here, we established a dynamic single-cell transcriptomic landscape of aged macaque TM, wherein we classified the outflow tissue into 12 cell subtypes and identified mitochondrial dysfunction as a prominent feature of TM aging. Furthermore, we divided TM cells into 13 clusters and performed an in-depth analysis on cluster 0, which had the highest aging score and the most significant changes in cell proportions between the two groups. Ultimately, we found that the APOE gene was an important differentially expressed gene in cluster 0 during the aging process, highlighting the close relationship between cell migration and extracellular matrix regulation, and TM function. Our work further demonstrated that silencing the APOE gene could increase migration and reduce apoptosis by releasing the inhibition on the PI3K-AKT pathway and downregulating the expression of extracellular matrix components, thereby increasing the aqueous outflow rate and maintaining intraocular pressure within the normal range. Our work provides valuable insights for future clinical diagnosis and treatment of glaucoma.

Keywords

single-cell transcriptomic atlas / macaque / trabecular meshwork / ocular outflow tissue / aging

References

[1] Adams CM, Stacy R, Rangaswamy N et al. Glaucoma—next generation therapeutics: impossible to possible. Pharm Res 2018;36:25.

[2] Angello JC, Pendergrass WR, Norwood TH et al. Proliferative potential of human fibroblasts: an inverse dependence on cell size. J Cell Physiol 2005;132:125–130.

[3] Beykin G, Norcia AM, Srinivasan VJ et al. Discovery and clinical translation of novel glaucoma biomarkers. Prog Retin Eye Res 2021;80:100875.

[4] Burton MJ, Ramke J, Marques AP et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Global Health 2021;9:e489–e551.

[5] Chen Z, Sun J, Li M et al. Effect of age on the morphologies of the human Schlemm’s canal and trabecular meshwork measured with swept-source optical coherence tomography. Eye (London, England) 2018;32:1621–1628.

[6] Chen K, Li Y, Zhang X et al. The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates. Cell Death Dis 2022;13:513.

[7] Childs BG, Baker DJ, Kirkland JL et al. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep 2014;15:1139–1153.

[8] Cristofalo VJ, Sharf BB. Cellular senescence and DNA synthesis. Exp Cell Res 1973;76:419–427.

[9] Croft MA, Lütjen-Drecoll E, Kaufman PL. Age-related posterior ciliary muscle restriction—a link between trabecular meshwork and optic nerve head pathophysiology. Exp Eye Res 2017;158:187–189.

[10] de Jesus BB, Blasco MA. Assessing cell and organ senescence biomarkers. Circ Res 2012;111:97–109.

[11] Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363–9367.

[12] Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009;9:550–562.

[13] Franke TF. PI3K/Akt: getting it right matters. Oncogene 2008;27:6473–6488.

[14] Fruman DA, Chiu H, Hopkins BD et al. The PI3K Pathway in human disease. Cell 2017;170:605–635.

[15] Gold ME, Kansara S, Nagi KS et al. Age-related changes in trabecular meshwork imaging. Biomed Res Int 2013;2013:1–6.

[16] Hui DY, Basford JE. Distinct signaling mechanisms for apoE inhibition of cell migration and proliferation. Neurobiol Aging 2005;26:317–323.

[17] Johnson M. What controls aqueous humour outflow resistance?. Exp Eye Res 2006;82:545–557.

[18] Jonas JB, Aung T, Bourne RR et al. Glaucoma. Lancet (London, England) 2017;390:2183–2193.

[19] Kass MA, Heuer DK, Higginbotham EJ et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701–713.

[20] Kumazaki T, Robetorye RS, Robetorye SC et al. Fibronectin expression increases during in vitro cellular senescence: correlation with increased cell area. Exp Cell Res 1991;195:13–19.

[21] Liu B, Mcnally S, Kilpatrick JI et al. Aging and ocular tissue stiffness in glaucoma. Surv Ophthalmol 2018;63:56–74.

[22] López-Otín C, Blasco MA, Partridge L et al. Hallmarks of aging: an expanding universe. Cell 2023;186:243–278.

[23] Macosko EZ, Basu A, Satija R et al. Highly parallel genomewide expression profiling of individual cells using nanoliter droplets. Cell 2015;161:1202–1214.

[24] Mahley RW, Huang Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 2012;76:871–885.

[25] Margeta MA, Yin Z, Madore C et al. Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma. Immunity 2022;55:1627–1644.e7.

[26] Nair KS, Srivastava C, Brown RV et al. GLIS1 regulates trabecular meshwork function and intraocular pressure and is associated with glaucoma in humans. Nat Commun 2021;12.

[27] Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96:614–618.

[28] Patel G, Fury W, Yang H et al. Molecular taxonomy of human ocular outflow tissues defined by single-cell transcriptomics. Proc Natl Acad Sci USA 2020;117:12856–12867.

[29] Picaud S, Dalkara D, Marazova K et al. The primate model for understanding and restoring vision. Proc Natl Acad Sci USA 2019;116:26280–26287.

[30] Rhee DJ, Haddadin RI, Kang MH et al. Matricellular proteins in the trabecular meshwork. Exp Eye Res 2009;88:694–703.

[31] Sherwood SW, Rush D, Ellsworth JL et al. Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc Natl Acad Sci USA 1988;85:9086–9090.

[32] Stamer WD, Acott TS. Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol 2012;23:135–143.

[33] Stamer WD, Clark AF. The many faces of the trabecular meshwork cell. Exp Eye Res 2017;158:112–123.

[34] Tham Y-C, Li X, Wong TY et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology 2014;121:2081–2090.

[35] Theocharis AD, Skandalis SS, Gialeli C et al. Extracellular matrix structure. Adv Drug Deliv Rev 2016;97:4–27.

[36] van Zyl T, Yan W, Mcadams A et al. Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis. Proc Natl Acad Sci USA 2020;117:10339–10349.

[37] Vavvas D, Song Q, Chen P et al. Role of the APOE ϵ2/ϵ3/ϵ4 polymorphism in the development of primary open-angle glaucoma: evidence from a comprehensive meta-analysis. PLoS One 2013;8:e82347.

[38] Weinreb RN, Leung CKS, Crowston JG et al. Primary open-angle glaucoma. Nat Rev Dis Primers 2016;2.

[39] Yan X, Wu S, Liu Q et al. Myocilin gene mutation induced autophagy activation causes dysfunction of trabecular meshwork cells. Front Cell Dev Biol 2022;10.

[40] Zou W, Fu L, Hu Y et al. Up-regulation of FOXD1 by YAP alleviates senescence and osteoarthritis. PLoS Biol 2019;17.

RIGHTS & PERMISSIONS

2024 The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.